Net Loss Per Share Attributable to Common Stockholders -Schedule of Antidilutive Shares (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Stock options | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive shares excluded from computation of earnings per share (in shares) | 0 | 2,089,000 |
| Unvested restricted stock units | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive shares excluded from computation of earnings per share (in shares) | 982,000 | 4,063,000 |
| Unvested performance stock units | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive shares excluded from computation of earnings per share (in shares) | 4,633,000 | 4,398,000 |
| ESPP purchase rights | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive shares excluded from computation of earnings per share (in shares) | 61,000 | 456,000 |